Lansforsakringar Fondforvaltning AB (publ)

Position in ZTS — Zoetis Inc.

CIK 2059323 Stockholm, V7

Back to ZTS Full portfolio

Position in ZTS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$9,688,740

-$36,828,786 QoQ

Shares Held

134,828

-65.7% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#236

of 1,408 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZTS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Lansforsakringar Fondforvaltning AB (publ) holds $29,337,552 across 4 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (33.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc. This page	134,828	$9,688,740
2	TEVA	Teva Pharmaceutical Industries Ltd	256,489	$8,689,847
3	UTHR	UNITED THERAPEUTICS Corp	11,892	$6,443,442
4	NBIX	Neurocrine Biosciences Inc	26,792	$4,515,523

All Filings in ZTS

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,688,740	134,828	-65.7%	Shares	Sole	2026-08-13
2026-03-31	$46,517,526	393,516	+19.8%	Shares	Sole	2026-04-23
2025-12-31	$41,343,822	328,595	+0.1%	Shares	Sole	2026-02-12
2025-09-30	$48,018,566	328,175	+1.3%	Shares	Sole	2025-11-10
2025-06-30	$50,537,001	324,059	-8.7%	Shares	Sole	2025-08-13
2025-03-31	$58,421,936	354,825	+1.1%	Shares	Sole	2025-05-14
2024-12-31	$57,183,867	350,972	—	Shares	Sole	2025-03-14
No filing history on record for this holder in this stock.